Start with the decision you actually need made
MDS is not one condition with one pathway. The World Health Organization classification and the International Prognostic Scoring System separate subtypes and risk groups that carry very different outlooks and treatment aims. Some people need monitoring; others are offered medicines to raise blood counts, transfusion support, or more intensive treatment including stem cell transplantation for selected higher-risk patients. Which of these applies depends on marrow findings, cytogenetics, molecular results, age, other illnesses and the patient's own goals.
That is why a useful overseas enquiry names the decision. Are you seeking confirmation of the diagnosis and risk category? A second opinion on whether current treatment remains appropriate? A view on whether a therapy used elsewhere is available in China? Or an assessment for a procedure such as transplantation? Each question needs different records and a different specialist. A vague request to 'review MDS' tends to produce a vague reply.
Write two or three sentences before you gather anything else: what has been diagnosed, what is being done now, and what you want the receiving team to address. Keep this separate from the full record set. It shapes which hospital department and which clinician's opinion are relevant, and it stops the enquiry drifting into a general search for care.
The records a haematology review depends on
MDS assessment is unusually record-dependent because the diagnosis and prognosis are built from serial data. A single blood count tells little. Clinicians look at trends in haemoglobin, neutrophils and platelets, the marrow aspirate and biopsy report, iron staining, cytogenetic results such as karyotype and fluorescence in situ hybridisation, and molecular panels where performed. Transfusion history, infection history and treatments tried so far all change the picture.
Ask your current centre for copies of the original reports rather than a summary letter alone. Pathology and genetics reports should be legible and complete, including reference ranges and the laboratory's interpretation. If a marrow sample was taken some time ago, the receiving team may want to know whether a repeat is advised; that is a clinical decision, not something to arrange independently before anyone has seen the file.
You do not need to send everything at first contact. A short summary with the diagnosis, recent counts and your question is enough to begin. The fuller set, including reports in English or with translation, can follow once someone has confirmed what is relevant. Ask how the provider prefers to receive large files and whether translated documents are needed for the particular hospital.
- Diagnosis and subtype as written in the marrow report
- Serial full blood counts with dates
- Marrow aspirate, biopsy and iron stain reports
- Karyotype, FISH and any molecular panel results
- Current and previous treatments, including transfusions and responses
- Other major conditions and current medicines
What a records-based opinion can and cannot settle
A specialist who reviews your file without examining you can comment on the reasonableness of the diagnosis and risk classification, discuss treatment categories, and identify questions the local team should answer. That is genuinely useful when the therapeutic path is unclear or when guidance in your country differs from practice elsewhere. It is not the same as a clinic consultation, and it cannot confirm fitness for intensive treatment or transplantation.
Be cautious with any reply that promises a specific therapy before the hospital has seen the marrow material and assessed you. Availability of a named medicine, a clinical trial place or a transplant slot is a hospital decision made after its own workup. A review can tell you whether a question is worth pursuing in China; it does not establish eligibility, and it does not guarantee that a bed or appointment will follow.
The same limit applies to prognosis. Risk scores give a statistical frame, not an individual forecast, and a clinician reviewing records remotely has less information than one examining the patient. Ask what the assessment is based on and which findings would change it. Those are fair questions, and a careful reviewer will answer them plainly.
Matching the question to the right hospital route
Haematology services differ between hospitals in China, as they do anywhere. Some centres concentrate on leukaemia and transplantation, others on chronic blood disorders and supportive care. The right route depends on your question: a diagnostic and risk review, a treatment plan for lower-risk disease, or an assessment for intensive therapy. Public tertiary hospitals and private international hospitals are both possible routes, and the choice affects language support, scheduling and how the visit is organised.
Ask directly whether the hospital has a haematology department that handles MDS and whether clinicians there can review records in English or need translated reports. Ask whether the initial contact would be a records review or an in-person visit, and what the hospital requires before it will offer an appointment. These are practical questions with factual answers, and they matter more than a hospital's general reputation.
If your case is complex, involving both blood and another organ system, a review drawing on more than one specialty may be appropriate. The scope and fee for that should be agreed in writing before it starts. For most MDS enquiries, a single haematology opinion is the sensible first step; broader review can follow if the clinician identifies a genuine cross-specialty question.
Costs, coordination and what to confirm in writing
Hospital charges for consultation, tests, treatment and stay are set by the hospital and paid to it. Our coordination fees are separate and are not offset against hospital bills. We do not publish a standard fee for treatment coordination, and we cannot give a meaningful estimate for MDS care without knowing the treatment under consideration. Ask the named hospital what its written quote covers and which items are billed separately.
For planning, distinguish three things: the hospital's clinical charges, any coordination or interpretation service you choose, and travel and accommodation. A records review may be arranged before any decision to travel, and an initial enquiry does not require buying a proxy consultation. If you later want a proxy consultation, a multidisciplinary review or appointment coordination, the current published fees are listed on our care-review and care-plan pages, and the scope is agreed before anything starts. Hospital consultation fees are separate from those coordination charges.
None of these figures tells you what MDS treatment will cost. That depends on the plan the hospital proposes after assessment. Ask for the quote in writing, itemised by the services it covers, and ask what would change it. Do not treat any range as a fixed price or a guarantee.
Practical preparation and the next step
Before travelling, confirm with the hospital what it expects: which records in which language, whether an in-person visit is needed for the first assessment, and how long the visit is likely to involve. Do not assume a single trip will complete everything. Ask whether follow-up can be done with your local team and what monitoring the hospital would want shared. These arrangements are specific to the provider and should be confirmed rather than assumed.
Keep your current treatment going and do not change medicines on the basis of an overseas enquiry. If your blood counts are falling, you have a fever or new bleeding, seek local urgent assessment rather than waiting for a planned review. Travel planning comes after clinical stability has been discussed with your treating team.
The practical next step is a short initial enquiry: your diagnosis, recent counts, current treatment and the specific question you want addressed. Our team checks whether the records and question are clear enough to route to a relevant haematology service and tells you what is missing. That initial review is free and is not a diagnosis or a promise of acceptance. The hospital decides suitability after its own assessment.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
